Q2
CAMP — Q2 2026 Financial Report Analysis
CAMP4's Q2 2026 net loss widened to $33.5M, but $20.9M of that was a non-cash charge on its share-sale agreement; underlying spending was flat, and a $50.1M second closing in August extends cash into the end of 2028, ahead of a first patient in its SYNGAP1 trial expected by end-2026.